Evidence map›Paper›PMID 23227900›Full record

ArticleBMC molecular biology2012

Alternative splicing of the neurofibromatosis type 1 pre-mRNA is regulated by the muscleblind-like proteins and the CUG-BP and ELAV-like factors.

Victoria A Fleming, Cuiyu Geng, Andrea N Ladd, Hua Lou

Open access · hybridAbstract read
In one paragraph

Article in BMC molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. T-Cell Intracellular Antigen 1-Like Protein in Physiology and Pathology.International journal of molecular sciences · 2022
    Review
  3. Article
  4. Case Report: A Synonymous Mutation inFrontiers in genetics · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Victoria A FlemingDepartment of Genetics, Case Western Reserve University, Cleveland, OH, 44106, USA.
Cuiyu Geng
Andrea N Ladd
Hua Lou
Case Western Reserve University · US

Funding

Hu proteins as novel splicing regulators in neuronsR01NS049103 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI LOU, HUA · 2004 to 2013
$2.3M
Role of pre-mRNA alternative splicing programs in heart and muscle developmentR01HL089376 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI LADD, ANDREA NICOLE · 2009 to 2014
$1.7M
NHLBI NIH HHS R01 HL089376NINDS NIH HHS R01 NS049103
6 · The paper itself

Abstract

backgroundAlternative splicing is often subjected to complex regulatory control that involves many protein factors and cis-acting RNA sequence elements. One major challenge is to identify all of the protein players and define how they control alternative expression of a particular exon in a combinatorial manner. The Muscleblind-like (MBNL) and CUG-BP and ELAV-Like family (CELF) proteins are splicing regulatory proteins, which function as antagonists in the regulation of several alternative exons. Currently only a limited number of common targets of MBNL and CELF are known that are antagonistically regulated by these two groups of proteins.

resultsRecently, we identified neurofibromatosis type 1 (NF1) exon 23a as a novel target of negative regulation by CELF proteins. Here we report that MBNL family members are positive regulators of this exon. Overexpression of MBNL proteins promote exon 23a inclusion in a low MBNL-expressing cell line, and simultaneous siRNA-mediated knockdown of MBNL1 and MBNL2 family members in a high MBNL-expressing cell line promotes exon 23a skipping. Importantly, these two groups of proteins antagonize each other in regulating inclusion of exon 23a. Furthermore, we analyzed the binding sites of these proteins in the intronic sequences upstream of exon 23a by UV cross-linking assays. We show that in vitro, in addition to the previously identified preferred binding sequence UGCUGU, the MBNL proteins need the neighboring sequences for optimal binding.

conclusionThis study along with our previous work that demonstrated roles for Hu, CELF, and TIA-1 and TIAR proteins in the regulation of NF1 exon 23a establish that this exon is under tight, complex control.

Indexed as

Alternative SplicingAnimalsBase SequenceBinding SitesCCAAT-Enhancer-Binding Protein-deltaCELF1 ProteinCell LineExonsHeLa CellsHumansNeurofibromatosis 1RatsRNA-Binding ProteinsRNA InterferenceRNA PrecursorsRNA, Small InterferingCCAAT-Enhancer-Binding Protein-deltaCEBPD protein, humanCELF1 ProteinCELF1 protein, humanMBNL1 protein, humanMBNL2 protein, humanRNA-Binding ProteinsRNA PrecursorsRNA, Small Interfering

Identifiers

PMID23227900
PMCPMC3558374
OpenAlexW2095493202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.